Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing triptorelin with/without flutamide plus external-beam radiation therapy versus external-beam radiation therapy alone in stage II/III pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • External beam radiation therapy
  • Triptorelin (triptorelin)
  • flutamide (flutamide)

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED